CSI Market
Sign In | Register

Astera Labs Inc (ALAB) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ALAB Annual Cash Flow →
The table below presents a historical view of Astera Labs Inc's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
3 Months 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income80.31
Depreciation & amortization3.71
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.35
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation48.91
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Operating Lease Right Of Use Asset Amortization Expense1.18
Class Of Warrants Or Right Contra Revenue2.10
Increase Decrease In Operating Lease Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-51.79
Increase (Decrease) in Accounts Payable-0.70
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-20.84
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets13.89
Other Working Capital0.00
Other Noncash Income (Expense)-1.31
Other net0.00
Payments for (Proceeds from) Other Operating Activities-1.20
Discontinued operations0.00
Net Cash flow from Operating Activities74.60
Investing Activities
Capital Expenditures-7.59
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities137.76
Payments to Acquire Available-for-sale Securities, Debt-156.63
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-65.05
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-2.50
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-94.01
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.08
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-167.68
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents167.68
Conversion Of Stock Amount Issued-
Exchange Of Common Stock To Redeemable Convertible Preferred Stock-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.08
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow67.01
Total Cash Flow-19.33
4 historic quarters locked

Sign in to unlock the full Astera Labs Inc cash flow history.

Sign In Create Free Account

About Astera Labs Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001736297-26-000035

Figures are derived from filed reports and may be restated. Historical data is subject to revision.